Engineering Halomonas bluephagenesis TD01 as a Robust Chassis for the Sustainable Production of Hyaluronic Acid
Biomolecules · 09.06.2026 · 16 (6) · 846
DOI: 10.3390/biom16060846 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 09.06.2026. Verfasst von Ehab Marwan-Abdelbaset und 2 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'a…. Hauptthemen laut MEDLINE: Hyaluronic Acid, Halomonas. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xi'an Jiaotong University, Central University of China.
Abstract (Originalsprache)
This study evaluates the development of Halomonas bluephagenesis TD01 as a novel, sustainable microbial platform for the production of hyaluronic acid (HA). Three distinct hyaluronan synthase genes (sezHasA and spHasA "Class I" from the Streptococcal group and pmHasA "class II") were heterologously expressed and compared, with the Class II synthase from Pasteurella multocida (pmHasA) emerging as the superior variant in rich media 60-LBG, achieving significantly higher titers of 0.88 g/L and molecular weight (Mw) of 1.15 MDa (Mega Daltons). Using a combination of Plackett–Burman design and Response Surface Methodology (RSM), the fermentation process was optimized, identifying initial pH, nitrogen source, and NaCl concentration as critical factors. These optimizations led to a maximum HA yield from 0.88 to 2.38 g/L (265% improvement) and Mw from 1.15 to 9.67 MDa. Furthermore, the study demonstrates precise tuning of HA molecular weight, ranging from 2.04 MDa to 9.67 MDa in a modified medium (40LBG-Y), by modulating L-arabinose induction levels. The structural integrity of the purified HA was confirmed via ESI-MS and 1H-NMR. These findings establish H. bluephagenesis TD01 as a robust Next-Generation Industrial Biotechnology (NGIB) chassis for the scalable and customizable production of HA with a minimal cost and high-molecular-weight HA for medical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, China.
- Department of Botany and Microbiology, Faculty of Science, Al-Azhar University, Nasr City, Cairo 11884, Egypt.
ORCID-Profile: Xiaoyun Lu
Förderung
- Xi'an Jiaotong University
- Central University of China
Zitieren
APA
Marwan-Abdelbaset, E., Lu, X., & Tan, D. (2026). Engineering Halomonas bluephagenesis TD01 as a Robust Chassis for the Sustainable Production of Hyaluronic Acid. Biomolecules, 16(6), 846. https://doi.org/10.3390/biom16060846
Vancouver
Marwan-Abdelbaset E, Lu X, Tan D. Engineering Halomonas bluephagenesis TD01 as a Robust Chassis for the Sustainable Production of Hyaluronic Acid. Biomolecules. 2026;16(6):846. doi:10.3390/biom16060846
BibTeX
@article{MarwanAbdelbaset2026,
author = {Marwan-Abdelbaset, Ehab and Lu, Xiaoyun and Tan, Dan},
title = {Engineering Halomonas bluephagenesis TD01 as a Robust Chassis for the Sustainable Production of Hyaluronic Acid},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {6},
pages = {846},
doi = {10.3390/biom16060846}
}
EUVIMED